Page last updated: 2024-09-04

rupatadine and web 2086

rupatadine has been researched along with web 2086 in 1 studies

Compound Research Comparison

Studies
(rupatadine)
Trials
(rupatadine)
Recent Studies (post-2010)
(rupatadine)
Studies
(web 2086)
Trials
(web 2086)
Recent Studies (post-2010) (web 2086)
1164362600831

Protein Interaction Comparison

ProteinTaxonomyrupatadine (IC50)web 2086 (IC50)
Platelet-activating factor receptorCavia porcellus (domestic guinea pig)0.1093
Platelet-activating factor receptorHomo sapiens (human)0.1735

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balsa, D; Ferrando, R; Forn, J; GarcĂ­a-Rafanell, J; Giral, M; Merlos, M; Puigdemont, A; Queralt, M1

Other Studies

1 other study(ies) available for rupatadine and web 2086

ArticleYear
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:1

    Topics: Administration, Oral; Animals; Azepines; Blood Pressure; Cyproheptadine; Dogs; Guinea Pigs; Histamine Antagonists; Male; Mice; Motor Activity; Platelet Activating Factor; Platelet Aggregation; Pyrilamine; Rabbits; Rats; Rats, Sprague-Dawley; Triazoles

1997